IGF1 and depressive disorder: Therefore, the aim of our study was to examine whether the intracerebroventricular administration of IGF-1 reduces anxiety and depressive disorders and influences peripheral inflammation in a rat model of sporadic Alzheimer’s disease, and whether this effect is dependent on the stage of the disease.